Screener
Krystal Biotech, Inc. KRYS Gain (loss) on disposal of assets
Discontinued — last reported Q4 '25
Gain (loss) on disposal of assets at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Krystal Biotech, Inc. in its filing.
Tagged under the XBRL concept us-gaap:GainLossOnDispositionOfIntangibleAssets.
The source filing: Krystal Biotech, Inc.’s 10-K, filed February 17, 2026.
- Filed
- Feb 17, 2026, 7:05 AM EST
- Fiscal year
- FY2025
- Accession
- 0001711279-26-000016
| (in thousands, except per share data) | Years Ended December 31, 2025 | Years Ended December 31, 2024 | Years Ended December 31, 2023 |
|---|---|---|---|
| Total operating expenses | 227,835 | 224,767 | 160,316 |
| Income (loss) from operations | 161,295 | 65,748 | (109,617) |
| Other income | |||
| Gain from sale of priority review voucher | — | — | 100,000 |
| Interest and other income, net | 28,176 | 29,608 | 22,514 |
| Income before income taxes | 189,471 | 95,356 | 12,897 |
| Income tax benefit (expense) | 15,360 | (6,197) | (1,965) |
| Net income | 204,831 | 89,159 | 10,932 |
Item 8. Financial Statements and Supplementary DataF-
FAQ
- What is Krystal Biotech, Inc.'s gain (loss) on disposal of assets?
- Krystal Biotech, Inc. (KRYS) reported gain (loss) on disposal of assets of $0 in Q4 2025.
- What does gain (loss) on disposal of assets mean?
- Gains or losses recognized on the disposal of businesses, property, equipment, investments, or other assets at prices above or below their carrying value.
Ask your AI about Krystal Biotech, Inc.'s gain (loss) on disposal of assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude